244 related articles for article (PubMed ID: 19133582)
1. [High-dose statin in ischemic stroke reduces the risk of recurrent stroke].
Crisby M; Olsson AG
Lakartidningen; 2008 Nov 26-Dec 9; 105(48-49):3541-3. PubMed ID: 19133582
[No Abstract] [Full Text] [Related]
2. [High dosage stain protects heart and brain from recurrence].
MMW Fortschr Med; 2008 Nov; 150(48):118-9. PubMed ID: 19125516
[No Abstract] [Full Text] [Related]
3. [Sequelae of the CARDS Study. LDL of 110 mg/dl still too high?].
Klose G
MMW Fortschr Med; 2004 Jun; 146(26):14. PubMed ID: 15529683
[No Abstract] [Full Text] [Related]
4. [After TIA and stroke: a statin for secondary prevention?].
MMW Fortschr Med; 2006 Jun; 148(24):10. PubMed ID: 16850798
[No Abstract] [Full Text] [Related]
5. Higher dose of statin medication may be better for older adults.
Mayo Clin Womens Healthsource; 2007 Dec; 11(12):3. PubMed ID: 17993998
[No Abstract] [Full Text] [Related]
6. [Ezetimib plus statin combination. A strong duo].
MMW Fortschr Med; 2002 Nov; 144(48):53. PubMed ID: 12532547
[No Abstract] [Full Text] [Related]
7. [How can lipid therapy be improved? Cardiologists insist on dual cholesterol inhibition].
MMW Fortschr Med; 2005 Nov; 147(45):54. PubMed ID: 16320655
[No Abstract] [Full Text] [Related]
8. [The TNT debate gives a lift to the debate about high-dose statins. Lower LDL cholesterol levels further reduce the cardiovascular risk].
Olsson AG
Lakartidningen; 2005 May 2-15; 102(18-19):1393-4. PubMed ID: 15929421
[No Abstract] [Full Text] [Related]
9. High-dose statin therapy for secondary prevention of stroke: stroke prevention by aggressive reduction in cholesterol levels study review.
Schwertz DW; Badellino KO
J Cardiovasc Nurs; 2008; 23(1):8-13. PubMed ID: 18158500
[TBL] [Abstract][Full Text] [Related]
10. High-dose atorvastatin therapy achieves 25% reduction in CV events in TNT substudy of diabetic patients.
Cardiovasc J S Afr; 2006; 17(4):206-7. PubMed ID: 17001426
[No Abstract] [Full Text] [Related]
11. [To lessen the cardiovascular risk of the diabetic patient. Atorvastatin of use for diabetic patients without coronary disease, too].
MMW Fortschr Med; 2005 Aug; 147(33-34):51. PubMed ID: 16138641
[No Abstract] [Full Text] [Related]
12. [Cholesterol goals are now easier to reach. Half LDL cholesterol with only one tablet daily].
MMW Fortschr Med; 2005 Nov; 147(45):55. PubMed ID: 16320656
[No Abstract] [Full Text] [Related]
13. Reduction in cardiovascular events with atorvastatin in type 2 diabetes.
Clearfield M
Curr Atheroscler Rep; 2006 Jan; 8(1):9-10. PubMed ID: 16455007
[No Abstract] [Full Text] [Related]
14. [Intensive LDL lowering to under 80 mg/dl: hypercholesteremia patients with stable coronary disease and diabetes profit especially significantly].
MMW Fortschr Med; 2005 Aug; 147(33-34):50-1. PubMed ID: 16138640
[No Abstract] [Full Text] [Related]
15. [CARDS confirms usefulness of LDL lowering in type 2 diabetics].
Bern VH
Praxis (Bern 1994); 2004 Oct; 93(44):1 p following 1830. PubMed ID: 15559908
[No Abstract] [Full Text] [Related]
16. [For coronary disease patients is certain: the lower the LDL the better].
MMW Fortschr Med; 2006 Jun; 148(24):6. PubMed ID: 16850797
[No Abstract] [Full Text] [Related]
17. High-dose atorvastatin and risk of atrial fibrillation in patients with prior stroke or transient ischemic attack: analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial.
Schwartz GG; Chaitman BR; Goldberger JJ; Messig M
Am Heart J; 2011 May; 161(5):993-9. PubMed ID: 21570534
[TBL] [Abstract][Full Text] [Related]
18. [Considerable LDL lowering is advantageous].
MMW Fortschr Med; 2005 Sep; 147(35-36):9. PubMed ID: 16180563
[No Abstract] [Full Text] [Related]
19. Atorvastatin treatment and vaccination efficacy.
Packard RR; Schlegel S; Senouf D; Burger F; Sigaud P; Perneger T; Siegrist CA; Mach F
J Clin Pharmacol; 2007 Aug; 47(8):1022-7. PubMed ID: 17548534
[No Abstract] [Full Text] [Related]
20. Rationale and design of China intensive lipid lowering with statins in acute coronary syndrome: the CHILLAS study.
Zhao SP; Peng DQ; Yu BL; Huo Y;
Am Heart J; 2009 Oct; 158(4):509-512.e1. PubMed ID: 19781407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
